These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1998997)

  • 61. Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: a pharmacokinetic study in pigs.
    van Ijken MG; de Bruijn EA; de Boeck G; ten Hagen TL; van der Sijp JR; Eggermont AM
    Ann Surg; 1998 Dec; 228(6):763-70. PubMed ID: 9860475
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hyperthermic isolated limb perfusion for malignant melanoma: response and survival.
    Bryant PJ; Balderson GA; Mead P; Egerton WS
    World J Surg; 1995; 19(3):363-8. PubMed ID: 7638989
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study.
    Olieman AF; Liénard D; Eggermont AM; Kroon BB; Lejeune FJ; Hoekstra HJ; Koops HS
    Arch Surg; 1999 Mar; 134(3):303-7. PubMed ID: 10088573
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hyperthermic isolated limb perfusion with tumor necrosis factor is a useful therapy for advanced melanoma of the limbs.
    Lejeune FJ; Eggermont AM
    J Clin Oncol; 2007 Apr; 25(11):1449-50; author reply 1450-1. PubMed ID: 17416870
    [No Abstract]   [Full Text] [Related]  

  • 65. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor.
    Fraker DL; Alexander HR; Andrich M; Rosenberg SA
    Cancer J Sci Am; 1995; 1(2):122-30. PubMed ID: 9166465
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma.
    Posner MC; Lienard D; Lejeune FJ; Rosenfelder D; Kirkwood J
    Cancer J Sci Am; 1995; 1(4):274-80. PubMed ID: 9166488
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; Nieweg OE
    J Surg Oncol; 2002 Apr; 79(4):252-5. PubMed ID: 11920783
    [No Abstract]   [Full Text] [Related]  

  • 68. Melphalan dosing regimens for management of recurrent melanoma by isolated limb perfusion: application of a physiological pharmacokinetic model based on melphalan distribution in the isolated perfused rat hindlimb.
    Wu ZY; Smithers BM; Roberts MS
    Melanoma Res; 1997 Jun; 7(3):252-64. PubMed ID: 9195565
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.
    Fraker DL; Alexander HR; Andrich M; Rosenberg SA
    J Clin Oncol; 1996 Feb; 14(2):479-89. PubMed ID: 8636761
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The use of a hand-held gamma detector improves the safety of isolated limb perfusion.
    Sardi A; Minton JP; Mojzisik C; Nieroda CA; Ferrara PJ; Hinkle GH; Thurston MO; Martin EW
    J Surg Oncol; 1989 Jul; 41(3):172-6. PubMed ID: 2664349
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hypoxic antiblastic stop-flow limb perfusion: clinical outcome and pharmacokinetic findings of a novel treatment for in transit melanoma metastases.
    Pilati P; Mocellin S; Miotto D; Fittà C; Casara D; Ori C; Scalerta R; Nitti D; Lise M; Rossi CR
    Oncol Rep; 2004 Oct; 12(4):895-901. PubMed ID: 15375519
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Results of cisplatin hyperthermic isolation perfusion for stage IIIA and IIIAB extremity melanoma.
    Fletcher WS; Pommier R; Small K
    Melanoma Res; 1994 Mar; 4 Suppl 1():17-9. PubMed ID: 8038590
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Isolated hyperthermic extremity perfusion with vindesine, dacarbazine and cisplatin in the treatment of malignant melanomas].
    Aigner KR; Jungbluth A; Link KH; Walther H; Müller H; Schwemmle K; Ringenberg T; Börger G; Ruppel R; Illig L
    Onkologie; 1984 Dec; 7(6):348-53. PubMed ID: 6396562
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb.
    Skene AI; Bulman AS; Williams TR; Thomas JM; Westbury G
    Br J Surg; 1990 Jul; 77(7):765-7. PubMed ID: 2383752
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.
    Hafström L; Rudenstam CM; Blomquist E; Ingvar C; Jönsson PE; Lagerlöf B; Lindholm C; Ringborg U; Westman G; Ostrup L
    J Clin Oncol; 1991 Dec; 9(12):2091-4. PubMed ID: 1960549
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Functional morbidity of hyperthermic isolated regional perfusion of the extremities.
    Olieman AF; Schraffordt Koops H; Geertzen JH; Kingma H; Hoekstra HJ; Oldhoff J
    Ann Surg Oncol; 1994 Sep; 1(5):382-8. PubMed ID: 7850539
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan.
    Vrouenraets BC; in't Veld GJ; Nieweg OE; van Slooten GW; van Dongen JA; Kroon BB
    Eur J Surg Oncol; 1999 Oct; 25(5):503-8. PubMed ID: 10529261
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma.
    Guadagni S; Russo F; Rossi CR; Pilati PL; Miotto D; Fiorentini G; Deraco M; Santinami M; Palumbo G; Valenti M; Amicucci G
    Am J Surg; 2002 Jan; 183(1):28-36. PubMed ID: 11869699
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Isolated limb perfusion with hyperthermia and chemotherapy: predictive factors for regional toxicity.
    Duprat Neto JP; Oliveira F; Bertolli E; Molina AS; Nishinari K; Facure L; Fregnani JH
    Clinics (Sao Paulo); 2012; 67(3):237-41. PubMed ID: 22473404
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hyperthermic perfusion with chemotherapy for melanoma of the extremities.
    Ghussen F; Krüger I; Smalley RV; Groth W
    World J Surg; 1989; 13(5):598-602. PubMed ID: 2815804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.